The Double-Icodextrin Dose Randomized Controlled Trial of a Double Icodextrin Dose for Older Patients on Incremental Continuous Ambulatory Peritoneal Dialysis

Key Points

• The double icodextrin dose improves fluid balance in older patients undergoing dialysis, enhancing treatment outcomes.
• Participants receiving the double dose showed greater fluid management capabilities, with efficiencies observed during the study period.
• Randomized controlled trial design employed to rigorously test dosing strategies among older patients on dialysis.
• The findings highlight the need for personalized dosing in older patients to improve their overall health outcomes.